Lund Melanoma Study Group
1 – 10 of 225
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
(
- Contribution to journal › Article
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
(
- Contribution to journal › Article
-
Mark
Cost of Illness of Head and Neck Cancer in Sweden
2024) In Value in Health(
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
2024) In Cancer Causes and Control(
- Contribution to journal › Article
-
Mark
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status
2024) In JAMA Surgery(
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Risk factors and diagnostic tools in the skin cancer era
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Time trends of the association of body mass index with mortality in 3.5 million young Swedish adults
(
- Contribution to journal › Article
-
Mark
Cohort profile : The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort
(
- Contribution to journal › Article